Smoking intensity, oxidative stress and chemotherapy in nonsmall cell lung cancer: A correlated prognostic study

BioScience Trends

Volumn 3, Issue 5, 2009, Pages 191-199

  Gupta, Abhilasha ^a   Srivastava, Shruti ^a   Prasad, Rajendra ^a   Natu, Shanker M ^a   Mittal, Balraj ^b   Negi, Mahendra P S ^c   Srivastava, Anand N ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Lung cancer; Oxidative stress; Pack year; Prognostic factor; Smoking intensity

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PLATINUM; PROGNOSIS; SMOKING;

EID: 77952515617     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, Hsieh LJ, Begg CB. Variations in lung cancer risk among smokers. J Natl Cancer Inst. 2003; 95:470-478.
2. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma: a study of 684 proved cases. J Am Med Assoc. 1950; 143:329-336.
3. Doll R, Hill AB. A study of the aetiology of carcinoma of the lung. Br Med J. 1952; 2:1271-1286.
4. Dresler CM. Is it more important to quit smoking than which chemotherapy is used? Lung Cancer. 2003; 39:119-124.
5. Barlesi F, Nanni-Metellus I, Breen D, Fina F, Astoul P, Martin PM. Non-small cell lung cancer-smokers or nonsmokers, does it matter? Lung Cancer. 2009; 63:430-432.
6. Hebert JR, Kabat GC. Distribution of smoking and its association with lung cancer: implications for studies on the association of fat with cancer. J Natl Cancer Inst. 1991; 83:872-874.
7. Sonnenfeld G, Griffith RB, Hudgens RW. The effect of smoke generation and manipulation variables on the cytotoxicity of mainstream and sidestream cigarette smoke to monolayer cultures of L-929 cells. Arch Toxicol. 1985; 58:120-122.
8. Pouli AE, Hatzinikolaou DG, Piperi C, Stavridou A, Psallidopoulos MC, Stavrides JC. The cytotoxic effect of volatile organic compounds of the gas phase of cigarette smoke on lung epithelial cells. Free Radic Biol Med. 2003; 34:345-355.
9. Coggins CR, Fouillet XL, Lam R, Morgan KT. Cigarette smoke induced pathology of the rat respiratory tract: a comparison of the effects of the particulate and vapour phases. Toxicology. 1980; 16:83-101.
10. Sullivan PD. Free radicals of benzo(a)pyrene and derivatives. Environ Health Perspect. 1985; 64:283-295.
11. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect. 1985; 64:111-126.
12. Nakayama T, Church DF, Pryor WA. Quantitative analysis of the hydrogen peroxide formed in aqueous cigarette tar extracts. Free Radic Biol Med. 1989; 7:9-15.
13. Zang LY, Stone K, Pryor WA. Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Radic Biol Med. 1995; 19:161-167.
14. Cerutti PA. Prooxidant states and tumor promotion. Science. 1985; 227:375-381.
15. Pryor WA, Hales BJ, Premovic PI, Church DF. The radicals in cigarette tar: their nature and suggested physiological implications. Science. 1983; 220:425-427.
16. Cross CE, van der Vliet A, O'Neill CA, Louie S, Halliwell B. Oxidants, antioxidants, and respiratory tract lining fluids. Environ Health Perspect. 1994; 102 SUPPL 10:185-191.
17. Janoff A, Pryor WA, Bengali ZH. NHLBI workshop summary. Effects of tobacco smoke components on cellular and biochemical processes in the lung. Am Rev Respir Dis. 1987; 136:1058-1064.
18. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest. 2004; 125:27-37.
19. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers--a different disease. Nat Rev Cancer. 2007; 7:778-790.
20. Toh CK. The changing epidemiology of lung cancer. Methods Mol Biol. 2009; 472:397-411.
21. Toh CK, Wong EH, Lim WT, Leong SS, Fong KW, Wee J, Tan EH. The impact of smoking status on the behavior and survival outcome of patients with advanced nonsmall cell lung cancer: a retrospective analysis. Chest. 2004; 126:1750-1756.
22. Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest. 2004; 126:347-351.
23. Fox JL, Rosenzweig KE, Ostroff JS. The effect of smoking status on survival following radiation therapy for non-small cell lung cancer. Lung Cancer. 2004; 44:287-293.
24. Bergman B, Sorenson S. Smoking and effect of chemotherapy in small cell lung cancer. Eur Respir J. 1988; 1:932-937.
25. Tan YK, Wee TC, Koh WP, Wang YT, Eng P, Tan WC, Seow A. Survival among Chinese women with lung cancer in Singapore: a comparison by stage, histology and smoking status. Lung Cancer. 2003; 40:237-246.
26. Yoshino I, Kawano D, Oba T, Yamazaki K, Kometani T, Maehara Y. Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma. Ann Thorac Surg. 2006; 81:1189-1193.
27. Beutler E, West C, Blume KG. The removal of leukocytes and platelets from whole blood. J Lab Clin Med. 1976; 88:328-333.
28. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95:351-358.
29. McCord JM, Fridovich I. The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J Biol Chem. 1969; 244:6056-6063.
30. Evans JC, Ellman GL. The ionization of cysteine. Biochim Biophys Acta. 1959; 33:574-576.
31. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982; 126:131-138.
32. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ. 1997; 315:980-988.
33. Stellman SD, Resnicow K. Tobacco smoking, cancer and social class. IARC Sci Publ. 1997: 229-250.
34. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008; 452:633-637.
35. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science. 1996; 274:430-432.
36. Schumacher JN, Green CR, Best FW, Newell MP. Smoke composition. An extensive investigation of the water-soluble portion of cigarette smoke. J Agric Food Chem. 1977; 25:310-320.
37. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med. 1996; 154:1055-1060.
38. Theron AJ, Richards GA, Van Rensburg AJ, Van der Merwe CA, Anderson R. Investigation of the role of phagocytes and anti-oxidant nutrients in oxidant stress mediated by cigarette smoke. Int J Vitam Nutr Res. 1990; 60:261-266.
39. Hemila H, Roberts P, Wikstrom M. Activated polymorphonuclear leucocytes consume vitamin C. FEBS Lett. 1984; 178:25-30.
40. Chung-man Ho J, Zheng S, Comhair SA, Farver C, Erzurum SC. Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res. 2001; 61:8578-8585.
41. Pignatelli B, Li CQ, Boffetta P, Chen Q, Ahrens W, Nyberg F, Mukeria A, Bruske-Hohlfeld I, Fortes C, Constantinescu V, Ischiropoulos H, Ohshima H. Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res. 2001; 61:778-784.
42. Petruzzelli S, Puntoni R, Mimotti P, Pulera N, Baliva F, Fornai E, Giuntini C. Plasma 3-nitrotyrosine in cigarette smokers. Am J Respir Crit Care Med. 1997; 156:1902-1907.
43. Cotgreave IA, Johansson U, Moldeus P, Brattsand R. The effect of acute cigarette smoke inhalation on pulmonary and systemic cysteine and glutathione redox states in the rat. Toxicology. 1987; 45:203-212.
44. Hoffmann D, Wynder EL. A study of tobacco carcinogenesis. XI. Tumor initiators, tumor accelerators, and tumor promoting activity of condensate fractions. Cancer. 1971; 27:848-864.
45. Petruzzelli S, Camus AM, Carrozzi L, et al. Longlasting effects of tobacco smoking on pulmonary drugmetabolizing enzymes: a case-control study on lung cancer patients. Cancer Res. 1988; 48:4695-4700.
46. Fujisawa T, Iizasa T, Saitoh Y, Sekine Y, Motohashi S, Yasukawa T, Shibuya K, Hiroshima K, Ohwada H. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol. 1999; 17:2086-2091.
47. Sanchez-Cespedes M, Ahrendt SA, Piantadosi S, Rosell R, Monzo M, Wu L, Westra WH, Yang SC, Jen J, Sidransky D. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res. 2001; 61:1309-1313.
48. Miyazaki K, Satoh H, Kagohashi K, Kurishima K, Ishikawa H, Ohtsuka M, Sekizawa K. Lung cancer patients with previous or simultaneous urologic cancers. Med Oncol. 2008; 25:443-446.
49. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997; 111:1710-1717.
50. Baser S, Shannon VR, Eapen GA, Jimenez CA, Onn A, Lin E, Morice RC. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest. 2006; 130:1784-1790.
51. Ebbert JO, Williams BA, Sun Z, Aubry MC, Wampfler JA, Garces YI, Meyer RL, Yang P. Duration of smoking abstinence as a predictor for non-small-cell lung cancer survival in women. Lung Cancer. 2005; 47:165-172.
52. Zhang B, Ferrence R, Cohen J, Bondy S, Ashley MJ, Rehm J, Jain M, Rohan T, Miller A. Smoking cessation and lung cancer mortality in a cohort of middle-aged Canadian women. Ann Epidemiol. 2005; 15:302-309.
53. Dresler CM, Bailey M, Roper CR, Patterson GA, Cooper JD. Smoking cessation and lung cancer resection. Chest. 1996; 110:1199-1202.
54. Duarte RL, Luiz RR, Paschoal ME. The cigarette burden (measured by the number of pack-years smoked) negatively impacts the response rate to platinum-based chemotherapy in lung cancer patients. Lung Cancer. 2008; 61:244-254.
55. Videtic GM, Stitt LW, Dar AR, Kocha WI, Tomiak AT, Truong PT, Vincent MD, Yu EW. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol. 2003; 21:1544-1549.
56. Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: association by tumour type. J Intern Med. 2002; 252:206-224.